- Home
- TXRH vs RPRX Comparison
TXRH vs RPRX Comparison
Compare TXRH & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- RPRX
- Stock Information
- Founded
- TXRH 1993
- RPRX 1996
- Country
- TXRH United States
- RPRX United States
- Employees
- TXRH N/A
- RPRX N/A
- Industry
- TXRH Restaurants
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TXRH Consumer Discretionary
- RPRX Health Care
- Exchange
- TXRH Nasdaq
- RPRX Nasdaq
- Market Cap
- TXRH 12.6B
- RPRX 13.9B
- IPO Year
- TXRH 2004
- RPRX 2020
- Fundamental
- Price
- TXRH $188.48
- RPRX $36.24
- Analyst Decision
- TXRH Buy
- RPRX Strong Buy
- Analyst Count
- TXRH 21
- RPRX 3
- Target Price
- TXRH $192.14
- RPRX $48.33
- AVG Volume (30 Days)
- TXRH 1.1M
- RPRX 3.8M
- Earning Date
- TXRH 08-07-2025
- RPRX 08-07-2025
- Dividend Yield
- TXRH 1.44%
- RPRX 2.43%
- EPS Growth
- TXRH 30.91
- RPRX 37.60
- EPS
- TXRH 6.48
- RPRX 2.45
- Revenue
- TXRH $5,499,763,000.00
- RPRX $2,263,845,000.00
- Revenue This Year
- TXRH $11.22
- RPRX $29.35
- Revenue Next Year
- TXRH $8.90
- RPRX $7.58
- P/E Ratio
- TXRH $29.08
- RPRX $14.77
- Revenue Growth
- TXRH 15.09
- RPRX 1.13
- 52 Week Low
- TXRH $148.73
- RPRX $24.05
- 52 Week High
- TXRH $206.04
- RPRX $36.56
- Technical
- Relative Strength Index (RSI)
- TXRH 50.66
- RPRX 61.10
- Support Level
- TXRH $185.25
- RPRX $35.51
- Resistance Level
- TXRH $189.30
- RPRX $36.56
- Average True Range (ATR)
- TXRH 3.64
- RPRX 0.65
- MACD
- TXRH -0.29
- RPRX -0.06
- Stochastic Oscillator
- TXRH 58.74
- RPRX 79.35
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.